NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Forcyte Biotechnologies

Forcyte Biotechnologies

Private
Los Angeles, CaliforniaHealthcare & Life Scienceshttps://forcytebio.com

Last Round

Seed

Jun 1, 2022

Total Funding Raised

$2.54M

Company Overview

Forcyte Biotechnologies is a biotechnology company that provides a proprietary, high-throughput screening platform called FLECS to quantify cellular contractile forces for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

mechanobiologydrug discoverydrug screeningcellular force generationphenotypic screeningCROcontract research organizationHTShigh-throughput screeningcell assaybioMEMScontractility assaylab-on-a-chippreclinical researchbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Forcyte Biotechnologies Comparables

Compare Forcyte Biotechnologies with similar companies based on industry and business-model similarity.

Forcyte Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cell4D
78%
Functional Fluidics
77%
Medera
77%

Forcyte Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 1, 2022
AcceleratorMar 23, 2021
GrantSep 11, 2019
SeedJan 15, 2019
GrantJul 24, 2018

Forcyte Biotechnologies Investors

Notable investors and investment history

Forcyte Biotechnologies investors
InvestorRounds
Pioneer FundSeed
NIH RADxGrant
Acequia CapitalSeed
Y CombinatorAccelerator, Seed

Forcyte Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Forcyte Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Forcyte Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California
Employee Range9
Year Founded2017
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.